Why is erythropoietin made in the kidney? The kidney functions as a Critmeter

American Journal of Kidney Diseases

Volumn 38, Issue 2, 2001, Pages 415-425

  Zhou, Wuding ^a   Sacks, Steven H ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Angiotensin II; Angiotensin II receptor blockers; Angiotensin converting enzyme (ACE) inhibitors; Chronic renal failure (CRF); Fractional sodium reabsorption; Oxygen consumption; Post transplant erythrocytosis; Renin angiotensin system; Sports anemia

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; RENIN;

ADRENERGIC SYSTEM; ARTICLE; BLOOD VOLUME; CHRONIC KIDNEY FAILURE; ERYTHROPOIESIS; FEEDBACK SYSTEM; HEMATOCRIT; HORMONAL REGULATION; HUMAN; KIDNEY PROXIMAL TUBULE; OXYGEN TISSUE LEVEL; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM ABSORPTION;

EID: 0034899022     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.26111     Document Type: Article

References (78)

1. The physiologic and clinical significance of erythropoietin
2. Co-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin
3. Identification of the renal erythropoietin-producing cells using transgenic mice
4. Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney
5. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: Correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration
6. Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia
7. Physiologic regulation and tissue localization of renal erythropoietin messenger RNA
8. Erythropoietin life span in rats with hypoplastic and hyperplastic bone marrows
9. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia
10. Erythropoietin
11. Oxygen sensing in the kidney and its relation to erythropoietin production
12. Molecular biology of erythropoietin
13. + reabsorption and other renal functions
14. Why the kidney?
15. Effects of hematocrit variations on regional hemodynamics and oxygen transport in the dog
16. The renal circulations
17. Metabolic basis of ion transport
18. Organization of the medullary circulation: Functional implications
19. Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex
20. Structure-function correlations in erythropoietin formation and oxygen sensing in the kidney
21. Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein
22. Erythropoietin production: Evidence for multiple oxygen sensing pathways
23. Oxygen sensing and signaling: Impact on the regulation of physiologically important genes
24. Modulation of transduced erythropoietin expression by iron
25. DNA methylation represses the expression of the human erythropoietin gene by two different mechanisms
26. Oxygen consumption and sodium reabsorption in the mammalian kidney
27. Regulation of erythropoietin production is related to proximal tubular function
28. Modulation of erythropoietin formation by changes in blood volume in conscious dogs
29. Cellular and intrarenal control of renin secretion
30. The renin-angiotensin system
31. Angiotensin actions in the kidney: Renewed insight into the old hormone
32. Renin-angiotensin system stimulates erythropoietin secretion in chronic hemodialysis patients
33. Erythropoietin deficiency in hyporeninemia
34. Influence of the renin-angiotensin system stimulation on erythropoietin production in patients with various forms of arterial hypertension
35. Enalapril (MK-421) and the white cell count and hematocrit
36. Effect of enalapril on hemoglobin and serum erythropoietin in patients with chronic nephropathy
37. Worsening of anemia induced by long-term use of captopril in hemodialysis patients
38. Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients
39. Angiotensin-converting enzyme inhibitors are associated with the need for increased recombinant human erythropoietin maintenance doses in hemodialysis patients
40. Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patents?
41. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients
42. Does captopril decrease the effect of human recombinant erythropoietin in hemodialysis patients?
43. ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients
44. ACE inhibitors do not decrease r-HuEPO response in patients with end-stage renal failure
45. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?
46. Enalapril-associated anemia in renal transplant recipients treated for hypertension
47. Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis
48. The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
49. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
50. Relation of serum erythropoietin levels to renal excretory function: Evidence for lowered set point for erythropoietin production in chronic renal failure
51. Serum erythropoietin concentration in chronic renal failure: Relationship to degree of anemia and excretory renal function
52. Erythropoietin production in chronic renal disease before and after transplantation
53. Clinical effects of bilateral nephrectomy
54. Erythropoietin production in patients with chronic renal failure
55. Effect of altitude on erythropoiesis and oxygen affinity in anaemic patients on maintenance dialysis
56. Multiple site estimates of erythropoietin and renin in polycythemic kidney transplant patients
57. Postrenal transplant erythrocytosis: Further evidence implicating erythropoietin production by the native kidneys
58. The influence of uremia on fractional sodium reabsorption by the proximal tubule of rats
59. Hypoxia of the renal medulla: Its implications for disease
60. Erythropoietin deficiency in type 1 diabetic patients is associated with decrease in fractional sodium reabsorption
61. Posttransplant erythrocytosis: An enigma revisited
62. Factors predictive of post transplant erythrocytosis
63. Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-I and its binding proteins
64. Effects of enalapril on erythrocytosis after renal transplantation
65. The beneficial effect of enalapril on erythrocytosis after renal transplantation
66. Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis
67. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: Efficacy, safety and action mechanisms
68. Effect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patients
69. Sports anemia
70. Development of pseudoanemia in marathon runners during a 20 day road race
71. "Sports anemia" - A real or apparent phenomenon in endurance-trained athletes?
72. Athletes' pseudoanaemia
73. Sports haematology
74. Erythropoietic adaptations to endurance training
75. Evaluation of erythropoietin in endurance runners
76. Plasma volume contraction and exercise-induced hypoxaemia modulate erythropoietin production in healthy humans